Table 5.
Comparison of the typology of general practitioners with moderate to high vaccine hesitancy identified in the present study and the original study by Verger et al.
| Vaccine Hesitancy (%) | |||
|---|---|---|---|
| Belgian GP (Present Study) |
French GP (from the Study by Verger et al. [11]) |
||
| Moderate to High N = 127 |
Moderate N = 166 |
High N = 56 |
|
| Perceived link between vaccines and potential severe side-effects (somewhat likely, very likely) | |||
| Influenza and Guillain-Barré | 20.5 | 29.9 | 66.2 |
| Hepatitis B and multiple sclerosis | 6.3 | 30.3 | 82.8 |
| Human papillomavirus (HPV) and multiple sclerosis | 4.7 | 15.2 | 70.9 |
| Aluminum and Alzheimer’s disease | 3.9 | 28.8 | 46.4 |
| Pandemrix and narcolepsy | 3.9 | 27.4 | 50.5 |
| Adjuvants and long-term complications | 11.8 | 48.2 | 88.5 |
| Perceived usefulness of vaccines (mostly agree, totally agree) | |||
| Some vaccines recommended by authorities are not helpful | 11.8 | 40.1 | 60.4 |
| Children are vaccinated against too many diseases | 5.5 | 36.5 | 62.4 |
| Referral frequency (often, always) | |||
| Measles–mumps–rubella (MMR) in unimmunized adolescents and young adults | 72.4 | 55.8 | 52.6 |
| Meningococcus C at 15 months | 51.2 | 52.8 | 30.6 |
| Catch-up for meningococcus C | 1.6 | 36.2 | 20.8 |
| Human papillomavirus (HPV) in girls 11–14 years old | 90.6 | 46.9 | 24.5 |
| Catch-up hepatitis B in adolescents | 21.3 | 41.5 | 29.7 |
| Flu in people with diabetes <65 years | 83.5 | 69.9 | 47.5 |